Undescended Testicle Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 5.18 Billion |
| Market Size (2030) | USD 7.33 Billion |
| CAGR (2025 - 2030) | 7.20% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order |
Undescended Testicle Market Analysis
The Undescended Testicle Market size is estimated at USD 5.18 billion in 2025, and is expected to reach USD 7.33 billion by 2030, at a CAGR of 7.2% during the forecast period (2025-2030).
Factors such as an increase in preterm births, a family history of undescended testicles, and the rise in demand for diagnosis of undescended testicles (UDT) in young men are expected to drive the market's growth during the forecast period. For instance, according to the June 2023 update by the Pan American Health Organization, one preterm baby is born out of every ten babies born globally. Similarly, according to the May 2023 update by the National Library of Medicine, about 3% of full-term and 30% of premature male infants are born with undescended testicles. Thus, owing to the high occurrence of undescended testicles among neonates and preterm births, the demand for undescended testicle diagnosis and treatment is likely to rise, thereby driving the market's growth during the forecast period.
Furthermore, the success rate of the treatment options of UDT increases the adoption of the same, which fuels the market growth over the forecast period. For instance, according to the May 2023 update by Mayo Clinic, Orchiopexy, the leading surgical procedure for addressing a solitary undescended testicle, boasts an impressive success rate nearing 100%. Typically, post-surgery, the likelihood of fertility issues diminishes significantly for those with a single undescended testicle. However, for individuals with two undescended testicles, the surgical intervention yields a more modest enhancement. Hence, owing to the positive and acceptable results offered by the UDT treatment options, the demand for the studied market is likely to rise, thereby bolstering the market's growth during the forecast period.
Thus, owing to the advantages and benefits offered by the UDT treatment and the increase in UDT cases across the world, the studied market is expected to witness significant growth during the forecast period. However, the high cost of UDT treatment is likely to hinder the market's growth during the forecast period.
Undescended Testicle Market Trends
The Neonates Segment is Expected to Witness a Positive Growth During the Forecast Period
Undescended testes (UDTs) frequently occur in male neonates, particularly in premature births. Typically, a baby's testicles migrate from the abdomen, traverse the groin, and settle in the scrotum during pregnancy. In about 5% of boys, this migration halts prematurely, causing the testicle to be positioned along the pathway rather than settling in the scrotum, thus resulting in UDT. Factors such as an increase in preterm birth cases, a rise in congenital disabilities, and congenital complications are expected to fuel the segment's growth during the forecast period.
For instance, as per the April 2024 update from the Centers for Disease Control and Prevention (CDC), the preterm birth rate stood at 10.41% in 2023, showing little variation from the 10.38% rate recorded in 2022. From 2022 to 2023, the rates of early preterm births (those occurring before 34 completed weeks of gestation) and late preterm births (occurring between 34 to 36 weeks) remained largely stable. Hence, due to the emerging presence of preterm birth rates, the chance of the development of UDT is higher, thereby fueling the segment growth during the forecast period. Additionally, an increase in investments by government authorities to support neonatal care is expected to drive the segment's growth during the forecast period.
Furthermore, congenital complications among neonates are one of the main reasons for developing UDT. For instance, according to the article published in January 2024 in the World Journal of Advanced Research and Reviews, cryptorchidism, a prevalent congenital anomaly, is frequently overlooked during initial neonatal assessments. Doctors, while administering first neonatal care, often overlook a thorough examination of the baby's external genitalia. Besides, parents may either be oblivious to the issue or not give it due attention. This lack of awareness can postpone the identification and subsequent treatment of an undescended testis. Furthermore, it's noteworthy that cryptorchidism frequently coexists with other congenital disorders. Thus, such related complications among neonates make them more prone to developing UDT, thereby creating a demand for UDT treatment and diagnosis among neonates.
Thus, owing to the increase in preterm births and the rise in the adoption of UDT diagnosis and treatment options among neonates, the segment is expected to witness significant growth during the forecast period.
North America is Expected to Witness a Significant Growth During the Forecast Period
North America is expected to witness significant market growth owing to better healthcare infrastructure, the presence of major industry players, and increased demand for early diagnosis of congenital disabilities and genital complications among babies. For instance, according to data published in March 2022 by the Canadian Paediatric Society, preterm births account for approximately 8% of all live births in Canada, with 30% occurring before 34 weeks gestational age (GA) and 70% occurring between 34 and 36 weeks. Hence, the significant cases of preterm birth in the region create a demand for early diagnosis of UDT, which drives the market over the study period.
Furthermore, increasing government initiatives to support neonatal healthcare in the North American region is expected to drive the market growth over the forecast period. For example, the New York Health Department introduced the Perinatal and Infant Community Health Collaboratives (PICHC) Initiative for 2022-2027. This initiative aims to bolster community-driven efforts, enhancing the health and well-being of birthing individuals and their families. Additionally, New York State is actively working to elevate perinatal and infant health outcomes, specifically targeting high-need, low-income, Medicaid-eligible families. Key priority outcomes include reducing preterm birth, low birth weight issues, and infant and maternal mortality. Thus, owing to such initiatives to support neonatal care, UDT diagnosis and treatment options in North America are expected to be utilized, thereby driving the market's growth during the forecast period.
Therefore, due to the increase in preterm birth cases and the rise in government initiatives to support neonatal care, North America is expected to witness significant growth over the forecast period.
Undescended Testicle Industry Overview
The undescended testicle market is consolidated in nature due to the presence of a few companies operating globally and regionally. A few of the major companies in the market are Fujifilm Holdings Corporation, Bharat Biotech, Medtronic, GE HealthCare, and Stryker.
Undescended Testicle Market Leaders
-
Bharat Biotech
-
Medtronic
-
Stryker
-
GE HealthCare
-
Fujifilm Holdings Corporation
- *Disclaimer: Major Players sorted in no particular order
Undescended Testicle Market News
- May 2024: USA Health Children’s & Women's Hospital's neonatal intensive care unit (NICU) was chosen to join The Tiny Baby Collaborative, an exclusive international research group. This initiative promotes cooperation and shared learning among hospitals that achieve exceptional outcomes for premature infants. The Tiny Baby Collaborative comprises around 25 hospitals from four countries. These hospitals consistently resuscitate children born at 22 to 23 weeks gestation and boast a history of successful outcomes. Additionally, neonatal staff from hospitals in Germany, Japan, and Sweden are active members of the group.
- June 2023: Wockhardt MamaCare unveiled 'Miracle,' a cutting-edge neonatal intensive care unit (NICU) and pediatric intensive care unit (PICU) dedicated to addressing health challenges in newborns and children. The NICU provides thorough care for infants facing structural abnormalities, infections, heart issues, and congenital disabilities.
Undescended Testicle Industry Segmentation
As per the scope of the report, an undescended testicle is a testicle that has not moved into the scrotum before birth. The undescended testicle (UDT) is also referred to as cryptorchidism.
The undescended testicle market is segmented by diagnosis and therapy, age group, and geography. By diagnosis, the market is segmented into magnetic resonance imaging, laparoscopy, and other diagnosis. By therapy, the market is segmented into open surgery and hormonal therapy. By age group, the market is segmented into neonates and children. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. The report offers the value (USD) for the above segments.
| By Diagnosis and Therapy | Diagnosis | Magnetic Resonance Imaging | |
| Laparoscopy | |||
| Other Diagnosis | |||
| Treatment | Open Surgery | ||
| Hormonal Therapy | |||
| By Age Group | Neonates | ||
| Children | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Rest of the World | |||
| Diagnosis | Magnetic Resonance Imaging |
| Laparoscopy | |
| Other Diagnosis | |
| Treatment | Open Surgery |
| Hormonal Therapy |
| Neonates |
| Children |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Rest of the World |
Undescended Testicle Market Market Research Faqs
How big is the Undescended Testicle Market?
The Undescended Testicle Market size is expected to reach USD 5.18 billion in 2025 and grow at a CAGR of 7.20% to reach USD 7.33 billion by 2030.
What is the current Undescended Testicle Market size?
In 2025, the Undescended Testicle Market size is expected to reach USD 5.18 billion.
Who are the key players in Undescended Testicle Market?
Bharat Biotech, Medtronic, Stryker, GE HealthCare and Fujifilm Holdings Corporation are the major companies operating in the Undescended Testicle Market.
Which is the fastest growing region in Undescended Testicle Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Undescended Testicle Market?
In 2025, the North America accounts for the largest market share in Undescended Testicle Market.
What years does this Undescended Testicle Market cover, and what was the market size in 2024?
In 2024, the Undescended Testicle Market size was estimated at USD 4.81 billion. The report covers the Undescended Testicle Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Undescended Testicle Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Undescended Testicle Market Industry Report
Statistics for the 2025 Undescended Testicle market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Undescended Testicle analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
